Stock EXPRS2 EXPRES2ION BIOTECH HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ExpreS2ion Biotech Holding AB

Equities

EXPRS2

SE0008348262

Delayed Nasdaq Stockholm
Other stock markets
 14:35:28 15/05/2024 BST 		5-day change 1st Jan Change
1.412 SEK -2.08% Intraday chart for ExpreS2ion Biotech Holding AB -4.59% -33.08%
04-16 ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate CI
02-21 ExpreS2ion Biotech JV Secures EUR10 Million Following Bavarian Nordic's Completion of COVID-19 Vaccine Trial MT

Evolution of the average Target Price on ExpreS2ion Biotech Holding AB

Price target over the last 5 years

History of analyst recommendation changes

84a0b42d115.qpouCNp7K0Xv1QQUrYqMYCYabiAxoWjNUEGavnfBiXs.-c1WMIIBeAyuhFF87P3-MmV1AHgB6Rr1JHX4jgGr8DOHokxBqjR4GrrsUQ~8d82fa7d32343a031116ab39279a3ca2

Analyst Recommendations on ExpreS2ion Biotech Holding AB

ExpreS2ion Biotech : Pareto Securities AS initiates equity research coverage of ExpreS2ion with a Buy rating and target price of 60 SEK per share AQ
ExpreS2ion Biotech : Analysguiden announces new research report with the target price for ExpreS2ion increased to 49 SEK per share AQ
ExpreS2ion Biotech : Analysguiden announces new research report with the target price for ExpreS2ion at 24 SEK per share AQ
ExpreS2ion Biotech : Analysguiden raises its target price for ExpreS2ion to 24 SEK per share AQ
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.442 SEK
Average target price
9 SEK
Spread / Average Target
+524.13%
High Price Target
9 SEK
Spread / Highest target
+524.13%
Low Price Target
9 SEK
Spread / Lowest Target
+524.13%

Consensus detail

Consensus revision (last 18 months)

Ratings for ExpreS2ion Biotech Holding AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EXPRS2 Stock
  4. Consensus ExpreS2ion Biotech Holding AB